Clinical Trial

Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To examine the impact of various administration routes of dexmedetomidine in conjunction with ultrasound-guided fascia iliaca block (FIB) on emergence agitation (EA) during the postoperative recovery period after hip replacement surgery.
Trial Details
NCT Number NCT06614010
Lead Sponsor Qianfoshan Hospital
Conditions Dexmedetomidine, Fascia Iliaca Block
Enrollment 207 participants
Start Date 2023-02-05
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-26